McKesson renews distribution deal with CVS Health

McKesson has renewed its distribution agreement with its largest client, CVS Health, the drug distributor announced during its earnings call May 9, according to Reuters.

Advertisement
Alia Paavola

The previous agreement was set to expire in June 2019. The renewed contract will run through 2023.

McKesson is the major distributor for the CVS pharmacy benefit unit, CVS Caremark.

More articles on pharmacy:
Insys execs guilty of opioid racketeering scheme
Walgreens shaking up C-suite
Generic drugmakers could thrive in a recession, Moody’s says

From manual to manageable: How AI and partnerships are transforming urology RCM

Recommended Whitepaper

Advertisement

Next Up in Pharmacy

  • 75 drugs currently in shortage: FDA

    The number of active drug shortages has declined sharply since June, according to the FDA’s drug shortage database. Seventy-five drugs…

    By: Mackenzie Bean

  • 6 recent updates on GLP-1 drugs

    From payer shifts to regulatory milestones, GLP-1 therapies for obesity and diabetes continued to reshape the healthcare landscape in December.…

    By: Ella Jeffries

  • 73 drugs lost exclusivity in 2025

    In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval…

    By: Paige Twenter
Advertisement

Comments are closed.